Technology | June 15, 2012

GE Healthcare Introduces Performance SPECT/CT System

Optima NM/CT640 offers CT image quality while keeping dose and ownership costs low

June 15, 2012 — At the 2012 Annual Meeting of the Society of Nuclear Medicine (SNM), GE Healthcare introduced the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT (single photon emission computed tomography/computed tomography) system, the Optima NM/CT 640. The new system offers nuclear medicine physicians the optimal balance of image quality, patient dose efficiency and low total cost of ownership.

Based on the 600 series’ SPECT technology found in the Discovery NM 630, this system integrates the general-purpose camera with a newly developed 4-slice CT designed for hybrid rather than standalone CT use. The CT, available in 2.5 mm and 5 mm slice thicknesses to optimize dose and resolution required for particular procedures, offers clinicians confidence with routinely low CT dose at 1-2 mSv for a 40-cm abdomen CT scan.

The Optima NM/CT 640 can be fully upgraded on location from a Discovery NM 630 SPECT-only system, and may be upgraded in the future to a 16-slice Discovery NM/CT 670, expanding not only its clinical capability, but offering the potential for research use.

With its small footprint the Optima NM/CT 640 requires minimal renovation and installation costs. With the benefit of optimized CT power, shielding and control room requirements are often eliminated, saving as much as $100,000 compared to higher CT-powered systems.

“At GE Healthcare, we are dedicated to pushing nuclear medicine to its full potential and investing in its future,” said Nathan Hermony, general manager, nuclear medicine, GE Healthcare. “We’re focused on developing equipment that helps customers address the challenges they are confronted with every day: high image quality, low dose and short exam times. Adding the Optima NM/CT 640 to our portfolio helps us strengthen this position, allows customers to upgrade as their needs expand, and continues to benefit clinicians and their patients.”

Adding all the benefits of the Xeleris Workstation with the Evolution technology to the Optima NM/CT 640 reduces the tradeoffs that are often required between acquisition time, dose and image quality by allowing clinicians to feel confident in their diagnosis, reducing time or injected patient dose by up to 50 percent in most scanning procedures while still maintaining excellent image quality. The Xeleris Workstation — which integrates new and existing nuclear medicine equipment, including legacy GE and non-GE devices — is designed to provide consistent results and enhanced workflow. Xeleris can keep clinicians connected to images and applications from picturing archiving and communications systems (PACS) and PCs with their institution and remotely.

For more information:

Related Content

The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain.

This figure shows two different brains that are aligned to a common template space for comparison. The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain. CREDIT: Zachariah Reagh

News | Nuclear Imaging | March 08, 2018
As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call...
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
Brain-scan guided emergency stroke treatment can save more lives
News | Neuro Imaging | January 25, 2018
January 25, 2018 – Advances in brain imagin...
PET Tracer Measures Damage From Multiple Sclerosis in Mouse Models
News | PET Imaging | January 24, 2018
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallma
Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Overlay Init